Home Genes
Leukemias Solid
Tumours Cancer-Prone
Deep Insight Portal
Teaching
X Y
1 2
3 4
5 6
7 8
9 10
11 12
13 14
15 16
17 18
19 20
21 22
NA
GROUPE FRANCAIS DE CYTOGENETIQUE ONCOLOGIQUE (GFCO)
Created in 1992 by A Bernheim, AM Cappodano, J Couturier following the GFCH (Groupe Français de Cytogénétique Hématologique
), the GFCO federates about 20 french laboratories in 1998. Most members
are also members of the GFCH, at times from its very begining. The aim is
to organize 3 meetings a year so that hospital cytogeneticists, clinicians,
and researchers have the opportunity to meet each other to share experience
and results obtained in each laboratory, to provide information about new
items, and to drive cooperative studies. Our working method of revision of
each cytogenetic file during the workshops is a guarantee of quality. A quality
assessement scheme is in progress since 1997,with a draft available, detailing
the various facettes of the clinical practice in cytogenetics applied to
solid tumours.
On going prospective scientific studies of the GFCO are the following :
- brain tumours (chair AM Cappodano);
- tumours of the kidney (apart from non papillary) (chair J Couturier)
- paediatric tumours (chair A Bernheim)
- bladder tumours (chair B Perissel)
- the GFCO supports the Atlas and is part of the referring process of the Atlas.
Secretary Dr Alain Bernheim
Laboratoire de Cytogénétique et de Génétique Oncologiques
UMR 1599 CNRS, Institut Gustave Roussy,
39 rue Camille Desmoulins
94805 Villejuif Cedex, France.
Tel. 33 (1) 45-59-54-16. Fax. 33 (1) 45-59-52-60
email: bernheim@infobiogen.fr